REGULATORY INTELLIGENCE·Recall
FDA Class II Recall: Westminster Pharmaceuticals' Metoprolol Tartrate Contaminated with N-nitroso-metoprolol
Westminster Pharmaceuticals LLC has initiated a Class II recall for Metoprolol Tartrate Tablets due to N-nitroso-metoprolol exceeding the Acceptable Daily Intake. This nationwide recall impacts 4,456 bottles, signaling critical supply chain vulnerabilities and heightened regulatory scrutiny on nitrosamine impurities, requiring immediate action from procurement and regulatory teams.
90-Day Activity